A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
IPM 018 is a double-blind, randomized, placebo-controlled study conducted at one site in
Belgium among 24 healthy, HIV-negative women to evaluate dapivirine release for 28 days from
matrix and reservoir intravaginal rings, each containing 25 mg of dapivirine, and to assess
safety and tolerability compared to placebo